Submission packages—such as drug master files for active ingredients—are pre-validated by an AI engine, allowing companies to ...
This episode of Pharma Pulse discusses how the FDA’s new plausible mechanism pathway, WeightWatchers’ plans to offer oral Wegovy, and emerging evidence on berberine are shaping the future of obesity ...
In third part of his Pharma Commerce video interview, Faisal Khan, a GRC solutions expert with Vanta, emphasizes the need for ...
Following LogiPharma USA 2025, the editors of Pharmaceutical Commerce explore the latest trends and key takeaways from the event, with a focus on the cold chain solutions sector.
This comes during a time when when Eli Lilly and Novo Nordisk have been garnering momentum—last week, the FDA added ...
Novartis has unveiled a 10,000-square-foot radioligand therapy (RLT) production plant in Carlsbad, CA, representing a move ...
This episode of Pharma Pulse explores how regulators modernize safety information for hormone therapy, new data that ...
In the first part of her Pharma Commerce video interview, Christy Christian, senior industry principal with Kinaxis, ...
Pharma Pulse: FDA Appoints Richard Pazdur as CDER Director Amid 340B Tensions and Novartis Expansion
This episode of Pharma Pulse discusses how Dr. Richard Pazdur’s appointment signals a new era for FDA drug evaluation, why hospitals are opposing the government’s 340B pilot program, and how Novartis ...
This episode of Pharma Pulse explores a major review finding no link between maternal acetaminophen use and autism or ADHD, ...
This episode of Pharma Pulse discusses FDA’s growing National Priority Voucher initiative, fresh data on oral semaglutide’s ...
Launching next year, the new CMS Innovation Center initiative—known as the GENEROUS Model—aims to align Medicaid drug prices ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback